相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Checkpoint inhibitor-associated immune arthritis
Laurent Arnaud et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Inflammation in ALS/FTD pathogenesis
Madelyn E. McCauley et al.
ACTA NEUROPATHOLOGICA (2019)
Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis
Javid J. Moslehi et al.
LANCET (2018)
Promises and limitations of immune cell-based therapies in neurological disorders
Xiaoming Hu et al.
NATURE REVIEWS NEUROLOGY (2018)
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
Michael A. Postow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Cancer immunotherapy using checkpoint blockade
Antoni Ribas et al.
SCIENCE (2018)
Immune Checkpoint Inhibitor-Associated Myositis: Expanding the Spectrum of Cardiac Complications of the Immunotherapy Revolution
Celine Anquetil et al.
CIRCULATION (2018)
Neurologic immune-related adverse events associated with adjuvant ipilimumab: report of two cases
Christine A. Garcia et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Increased Reporting of Immune Checkpoint Inhibitor-Associated Diabetes
Jordan J. Wright et al.
DIABETES CARE (2018)
Immune Checkpoint Inhibitor Toxicity in 2018
Douglas B. Johnson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study
Joe-Elie Salem et al.
LANCET ONCOLOGY (2018)
Inflammation: Bridging Age, Menopause and APOEε4 Genotype to Alzheimer's Disease
Aarti Mishra et al.
FRONTIERS IN AGING NEUROSCIENCE (2018)
Increased long QT and torsade de pointes reporting on tamoxifen compared with aromatase inhibitors
Virginie Grouthier et al.
HEART (2018)
Neurological adverse events associated with immune checkpoint inhibitors: Review of the literature
S. Cuzzubbo et al.
EUROPEAN JOURNAL OF CANCER (2017)
Tumor Mutational Burden and Response Rate to PD-1 Inhibition
Mark Yarchoan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Neurologic Serious Adverse Events Associated with Nivolumab Plus Ipilimumab or Nivolumab Alone in Advanced Melanoma, Including a Case Series of Encephalitis
James Larkin et al.
ONCOLOGIST (2017)
Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy
Lisa Zimmer et al.
EUROPEAN JOURNAL OF CANCER (2016)
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
Douglas B. dbj Johnson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Myasthenia Gravis Induced by Ipilimumab in Patients With Metastatic Melanoma
Douglas B. Johnson et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Shrinkage observed-to-expected ratios for robust and transparent large-scale pattern discovery
G. Niklas Noren et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2013)
Multiple sclerosis
Alyssa Nylander et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
VigiBase, the WHO Global ICSR Database System: Basic facts
Marie Lindquist
DRUG INFORMATION JOURNAL (2008)
Anti-HERG activity and the risk of drug-induced arrhythmias and sudden death
ML De Bruin et al.
EUROPEAN HEART JOURNAL (2005)
The reporting odds ratio and its advantages over the proportional reporting ratio
KJ Rothman et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2004)
分享论文
